230 related articles for article (PubMed ID: 32853630)
1. TRIP6 accelerates the proliferation and invasion of cervical cancer by upregulating oncogenic YAP signaling.
Yang F; Li L; Zhang J; Zhang J; Yang L
Exp Cell Res; 2020 Nov; 396(1):112248. PubMed ID: 32853630
[TBL] [Abstract][Full Text] [Related]
2. TTPAL Promotes Colorectal Tumorigenesis by Stabilizing TRIP6 to Activate Wnt/β-Catenin Signaling.
Gou H; Liang JQ; Zhang L; Chen H; Zhang Y; Li R; Wang X; Ji J; Tong JH; To KF; Sung JJY; Chan FKL; Fang JY; Yu J
Cancer Res; 2019 Jul; 79(13):3332-3346. PubMed ID: 31018940
[TBL] [Abstract][Full Text] [Related]
3. TRIP6 promotes tumorigenic capability through regulating FOXC1 in hepatocellular carcinoma.
Wang F; Zhang B; Xu X; Zhu L; Zhu X
Pathol Res Pract; 2020 Apr; 216(4):152850. PubMed ID: 32046874
[TBL] [Abstract][Full Text] [Related]
4. The Zyxin-related protein thyroid receptor interacting protein 6 (TRIP6) is overexpressed in Ewing's sarcoma and promotes migration, invasion and cell growth.
Grunewald TG; Willier S; Janik D; Unland R; Reiss C; Prazeres da Costa O; Buch T; Dirksen U; Richter GH; Neff F; Burdach S; Butt E
Biol Cell; 2013 Nov; 105(11):535-47. PubMed ID: 24033704
[TBL] [Abstract][Full Text] [Related]
5. TRIP6, as a target of miR-7, regulates the proliferation and metastasis of colorectal cancer cells.
Ling Y; Cao C; Li S; Qiu M; Shen G; Chen Z; Yao F; Chen W
Biochem Biophys Res Commun; 2019 Jun; 514(1):231-238. PubMed ID: 31029422
[TBL] [Abstract][Full Text] [Related]
6. Characterization of TRIP6-dependent nasopharyngeal cancer cell migration.
Fei J; Li J; Shen S; Zhou W
Tumour Biol; 2013 Aug; 34(4):2329-35. PubMed ID: 23576104
[TBL] [Abstract][Full Text] [Related]
7. Targeting Thyroid Receptor Interacting Protein 6 by MicroRNA-589-5p Inhibits Cell Proliferation, Migration, and Invasion in Endometrial Carcinoma.
Wang Y; Dong L; Liu Y
Cancer Biother Radiopharm; 2019 Oct; 34(8):529-536. PubMed ID: 31424277
[No Abstract] [Full Text] [Related]
8. Metastatic Colorectal Cancer Rewrites Metabolic Program Through a Glut3-YAP-dependent Signaling Circuit.
Kuo CC; Ling HH; Chiang MC; Chung CH; Lee WY; Chu CY; Wu YC; Chen CH; Lai YW; Tsai IL; Cheng CH; Lin CW
Theranostics; 2019; 9(9):2526-2540. PubMed ID: 31131051
[No Abstract] [Full Text] [Related]
9. Nogo-B fosters HCC progression by enhancing Yap/Taz-mediated tumor-associated macrophages M2 polarization.
Zhao X; Wang X; You Y; Wen D; Feng Z; Zhou Y; Que K; Gong J; Liu Z
Exp Cell Res; 2020 Jun; 391(1):111979. PubMed ID: 32246992
[TBL] [Abstract][Full Text] [Related]
10. MiR-216a-3p suppresses the proliferation and invasion of cervical cancer through downregulation of ACTL6A-mediated YAP signaling.
Zhao J; Li L; Yang T
J Cell Physiol; 2020 Dec; 235(12):9718-9728. PubMed ID: 32401366
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA‑138‑5p regulates neural stem cell proliferation and differentiation in vitro by targeting TRIP6 expression.
Wang J; Li J; Yang J; Zhang L; Gao S; Jiao F; Yi M; Xu J
Mol Med Rep; 2017 Nov; 16(5):7261-7266. PubMed ID: 28944841
[TBL] [Abstract][Full Text] [Related]
12. TRIP6 inhibits Hippo signaling in response to tension at adherens junctions.
Dutta S; Mana-Capelli S; Paramasivam M; Dasgupta I; Cirka H; Billiar K; McCollum D
EMBO Rep; 2018 Feb; 19(2):337-350. PubMed ID: 29222344
[TBL] [Abstract][Full Text] [Related]
13. TRIP6 regulates p27 KIP1 to promote tumorigenesis.
Lin VT; Lin VY; Lai YJ; Chen CS; Liu K; Lin WC; Lin FT
Mol Cell Biol; 2013 Apr; 33(7):1394-409. PubMed ID: 23339869
[TBL] [Abstract][Full Text] [Related]
14. SOX18 exerts tumor-suppressive functions in papillary thyroid carcinoma through inhibition of Wnt/β-catenin signaling.
Geng Q; Deng H; Fu J; Cui F
Exp Cell Res; 2020 Nov; 396(1):112249. PubMed ID: 32858034
[TBL] [Abstract][Full Text] [Related]
15. TRIP6 promotes cell proliferation in hepatocellular carcinoma via suppression of FOXO3a.
Zhao W; Dai Y; Dai T; Xie T; Su X; Li J; Zhou X; Meng K; Zhao X
Biochem Biophys Res Commun; 2017 Dec; 494(3-4):594-601. PubMed ID: 29080747
[TBL] [Abstract][Full Text] [Related]
16. Platelet‑derived growth factor‑BB mediates pancreatic cancer malignancy via regulation of the Hippo/Yes‑associated protein signaling pathway.
Li T; Guo T; Liu H; Jiang H; Wang Y
Oncol Rep; 2021 Jan; 45(1):83-94. PubMed ID: 33416116
[TBL] [Abstract][Full Text] [Related]
17. ANLN-induced EZH2 upregulation promotes pancreatic cancer progression by mediating miR-218-5p/LASP1 signaling axis.
Wang A; Dai H; Gong Y; Zhang C; Shu J; Luo Y; Jiang Y; Liu W; Bie P
J Exp Clin Cancer Res; 2019 Aug; 38(1):347. PubMed ID: 31395079
[TBL] [Abstract][Full Text] [Related]
18. LncRNA HOTAIR promotes the migration and invasion of cervical cancer through DNMT3B/LATS1/ YAP1 pS127 axis.
Zhang Z; Zhou X; Li J; Meng Q; Zheng P
Reprod Biol; 2024 Jun; 24(2):100893. PubMed ID: 38754347
[TBL] [Abstract][Full Text] [Related]
19. MIR31HG exhibits oncogenic property and acts as a sponge for miR-361-3p in cervical carcinoma.
Li Y
Biochem Biophys Res Commun; 2020 Sep; 529(4):890-897. PubMed ID: 32819595
[TBL] [Abstract][Full Text] [Related]
20. TRIP6 accelerates the proliferation and migration of fetal airway smooth muscle cells by enhancing YAP activation.
Wei F; Hao Y
Int Immunopharmacol; 2020 Mar; 82():106366. PubMed ID: 32151960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
